Mandate

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 1,414 million, before issue costs.

The share issue is directed to a number of selected international and Swedish reputable investors and life sciences specialist investors, on the basis of an accelerated bookbuilding process conducted by Carnegie Investment Bank AB (publ), Cowen, DNB Markets, a part of DNB Bank ASA, Jefferies International Limited and Kempen & CO N.V.

 

Oncopeptides is a clinical development pharmaceutical company focused on conducting anti‑cancer research to develop treatments for the benefit of patients. The company’s shares are admitted to trading on Nasdaq Stockholm.

 

Vinge’s team has consisted of Dain Hård Nevonen, Sofie Bjärtun, Linnéa Sellström and Hampus Olsson.

 

Related

Vinge has advised Fidelio Capital AB in connection with its investment in Newsec AB

Vinge has advised Fidelio Capital AB in connection with the company’s investment in Newsec AB, a leading property asset management and advisory company in the Nordic and Baltic regions. Fidelio Capital AB has a vision to expand the business through, among other things, acquisitions and digital development within property management.
June 09, 2025

Vinge has advised Brand Equity Group Sweden AB in connection with its acquisition of PREVOX REKLAM Aktiebolag and Jonas Anderzson of Sweden AB

Vinge has advised Brand Equity Group Sweden AB in connection with its parallel acquisitions of PREVOX REKLAM Aktiebolag and Jonas Anderzson of Sweden AB. The acquired businesses are engaged in product media activities, with a primary focus on marketing and production of product media. Through these acquisitions, Brand Equity Group Sweden AB strengthens its position in Sweden within product media and brand communication.
June 09, 2025

Vinge advises Lagercrantz Group in connection with the acquisition of ORAX

Lagercrantz Group has acquired all shares in AB ORAX, a leading provider of products for management and maintenance in the funeral and cemetery sector.
June 04, 2025